0001250853-13-000111.txt : 20131107 0001250853-13-000111.hdr.sgml : 20131107 20131107202046 ACCESSION NUMBER: 0001250853-13-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131105 FILED AS OF DATE: 20131107 DATE AS OF CHANGE: 20131107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lion Biotechnologies, Inc. CENTRAL INDEX KEY: 0001425205 STANDARD INDUSTRIAL CLASSIFICATION: ARRANGEMENT OF TRANSPORTATION OF FREIGHT & CARGO [4731] IRS NUMBER: 753254381 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21900 BURBANK BLVD. STREET 2: THIRD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 BUSINESS PHONE: 818-992-3126 MAIL ADDRESS: STREET 1: 21900 BURBANK BLVD. STREET 2: THIRD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 FORMER COMPANY: FORMER CONFORMED NAME: Genesis Biopharma, Inc DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP DATE OF NAME CHANGE: 20080128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singh Manish CENTRAL INDEX KEY: 0001550588 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53127 FILM NUMBER: 131202301 MAIL ADDRESS: STREET 1: 21900 BURBANK BOULEVARD, 3RD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-11-05 0 0001425205 Lion Biotechnologies, Inc. LBIO 0001550588 Singh Manish 21900 BURBANK BOULEVARD, 3RD FLOOR WOODLAND HILLS CA 91367 1 1 1 0 President & CEO Common Stock 2013-11-05 4 A 0 607500 A 1813500 D Common Stock 2013-11-05 4 P 0 125000 2 A 1938500 D Warrant 2.5 2013-11-05 4 A 0 125000 A 2013-11-05 2018-11-05 Common stock 125000 125000 D These shares were issued to the reporting person pursuant to a merger agreement between Lion Biotechnologies, Inc. and Genesis Biopharma, Inc. dated July 24, 2013 whereby upon the completion of a financing within 12 months following the merger, additional shares would be issued to the reporting person. The Issuer completed a financing on November 5, 2013. These warrant shares were acquired in a recent offering by the Issuer of common stock and warrants whereby a purchase of each share of common stock included a warrant exercisable for one share of common stock at $2.50 per share. /s/ Manish Singh 2013-11-07